New aspects of intestinal carcinogenesis by 1,2-dimethylhydrazine dihydrochloride (DMH) and the influence of antilymphocyte globuline (ALG) on its progress.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D004064:Digestive System / Q000473:pathology; D004127:Dimethylhydrazines; D005770:Gastrointestinal Neoplasms / Q000139:chemically induced*; D007413:Intestinal Mucosa / Q000187:drug effects; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008763:Methylhydrazines; D051381:Rats; D013154:Spleen / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology
D000961:Antilymphocyte Serum; D004127:Dimethylhydrazines; D008763:Methylhydrazines